Telix Pharmaceuticals Limited (TLPPF)

Telix Pharmaceuticals Revenue

Telix Pharmaceuticals had revenue of 818.40M AUD in the twelve months ending March 31, 2024, with 141.75% growth year-over-year. Revenue in the quarter ending March 31, 2024 was 175.00M AUD with 58.49% year-over-year growth. In the year 2023, Telix Pharmaceuticals had annual revenue of 502.55M AUD with 222.18% growth.

• Revenue (ttm): 818.40M AUD
• Revenue Growth: +141.75%
• P/S Ratio: 7.69
• Revenue / Employee: 1,972,059 AUD
• Employees: 415
• Market Cap: 4.26B USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	502.55M	346.56M	222.18%
Dec 31, 2022	155.98M	151.09M	3,084.65%
Dec 31, 2021	4.90M	218.00K	4.66%
Dec 31, 2020	4.68M	1.20M	34.29%
Dec 31, 2019	3.49M	3.29M	1,685.88%
Dec 31, 2018	195.14K	-	-